1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (2015-2028)
1.4.2 Gene Induced Immunotherapy
1.4.3 Oncolytic Virotherapy
1.4.4 Gene Transfer
1.5 Market by Application
1.5.1 Global Gene Therapies for Cancer Treatment Market Share by Application (2015-2028)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gene Therapies for Cancer Treatment Market Size
2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions (2015-2028)
2.2.2 Gene Therapies for Cancer Treatment Market Share by Regions (2015-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gene Therapies for Cancer Treatment Market Size by Manufacturers
3.1.1 Global Gene Therapies for Cancer Treatment Revenue by Manufacturers (2015-2020)
3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Manufacturers (2015-2020)
3.1.3 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Gene Therapies for Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Gene Therapies for Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gene Therapies for Cancer Treatment Market Size by Type (2015-2020)
4.2 Global Gene Therapies for Cancer Treatment Market Size by Application (2015-2020)
5 United States
5.1 United States Gene Therapies for Cancer Treatment Market Size (2015-2020)
5.2 Gene Therapies for Cancer Treatment Key Players in United States
5.3 United States Gene Therapies for Cancer Treatment Market Size by Type
5.4 United States Gene Therapies for Cancer Treatment Market Size by Application
6 Europe
6.1 Europe Gene Therapies for Cancer Treatment Market Size (2015-2020)
6.2 Gene Therapies for Cancer Treatment Key Players in Europe
6.3 Europe Gene Therapies for Cancer Treatment Market Size by Type
6.4 Europe Gene Therapies for Cancer Treatment Market Size by Application
7 China
7.1 China Gene Therapies for Cancer Treatment Market Size (2015-2020)
7.2 Gene Therapies for Cancer Treatment Key Players in China
7.3 China Gene Therapies for Cancer Treatment Market Size by Type
7.4 China Gene Therapies for Cancer Treatment Market Size by Application
8 Japan
8.1 Japan Gene Therapies for Cancer Treatment Market Size (2015-2020)
8.2 Gene Therapies for Cancer Treatment Key Players in Japan
8.3 Japan Gene Therapies for Cancer Treatment Market Size by Type
8.4 Japan Gene Therapies for Cancer Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gene Therapies for Cancer Treatment Market Size (2015-2020)
9.2 Gene Therapies for Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type
9.4 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application
10 India
10.1 India Gene Therapies for Cancer Treatment Market Size (2015-2020)
10.2 Gene Therapies for Cancer Treatment Key Players in India
10.3 India Gene Therapies for Cancer Treatment Market Size by Type
10.4 India Gene Therapies for Cancer Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Gene Therapies for Cancer Treatment Market Size (2015-2020)
11.2 Gene Therapies for Cancer Treatment Key Players in Central & South America
11.3 Central & South America Gene Therapies for Cancer Treatment Market Size by Type
11.4 Central & South America Gene Therapies for Cancer Treatment Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapies for Cancer Treatment Introduction
12.1.4 Novartis Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
12.1.5 Novartis Recent Development
12.2 Kite Pharma
12.2.1 Kite Pharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapies for Cancer Treatment Introduction
12.2.4 Kite Pharma Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
12.2.5 Kite Pharma Recent Development
12.3 Amgen
12.3.1 Amgen Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapies for Cancer Treatment Introduction
12.3.4 Amgen Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
12.3.5 Amgen Recent Development
12.4 Shanghai Sunway
12.4.1 Shanghai Sunway Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapies for Cancer Treatment Introduction
12.4.4 Shanghai Sunway Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
12.4.5 Shanghai Sunway Recent Development
12.5 Sibiono
12.5.1 Sibiono Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapies for Cancer Treatment Introduction
12.5.4 Sibiono Revenue in Gene Therapies for Cancer Treatment Business (2015-2020)
12.5.5 Sibiono Recent Development
13 Market Forecast 2021-2028
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2028)
13.10 Market Size Forecast by Application (2021-2028)
14 Analysts Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details